Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PQ912 phase 2a trial in early Alzheimer's disease
2014-001967-11Phase 2Completed
- Sponsor
- Vivoryon Therapeutics N.V.
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing PQ912 with Placebo (2 arms). Primary endpoints: Time to dose adjustment, Number of serious and non-serious adverse events and 1 more. Started Aug 2014; status: completed.
02
Drugs
varoglutamstat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2014-001967-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001967-11.